Bellerophon Therapeutics, Inc.: cashflow_operating

Value{"amount": -30588000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"}
Period2014-01-01 – 2014-03-31
Statuscurrent
EntityBellerophon Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001104659-15-038673 · Open the official SEC filing →
Retrieved: 2026-08-19T16:22:41.642204+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001600132/cashflow-operating/2014-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/68045f43-3ed7-4ee8-a81b-c8b21726b2ae

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies